Monitor for actual sales in upcoming days; given this is an officer selling recently vested equity and recent insider selling totals $2.6M in 30 days, consider this a bearish signal ahead of potential earnings or clinical updates. Pair with upcoming trading volume for confirmation of execution.
Price Chart
Executive Summary
Lucera Erick, an officer of Dyne Therapeutics, filed a Form 144 to notify intent to sell up to 57,270 shares of common stock, with an approximate value of $1.65 million based on recent market prices. The shares are from restricted stock units and equity compensation, and the filing was submitted by Stifel Nicolaus & Company Inc as attorney-in-fact.
Key Facts
- Reporting owner: Lucera Erick, officer of Dyne Therapeutics
- Shares proposed for sale: 57,270
- Approximate dollar value: $1,650,271 (based on $28.81/share)
- Shares acquired via: Restricted Stock Units and equity compensation
- Acquisition date: March 31, 2026
- Filing date: April 1, 2026
- Broker: Stifel Nicolaus & Company Inc, acting as attorney-in-fact
Financial Impact
$1.65 million in insider selling intent, representing full liquidation of recently vested RSUs
Risk Factors
- Insider selling may accelerate if near-term catalysts disappoint
- Lack of offsetting insider buying increases perception of weak confidence
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001972481-26-000124 |
| Document: 0001972481-26-000124-index.html | 0001972481-26-000124 |
| Document: 0001972481-26-000124.txt | 0001972481-26-000124 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 6w ago | Insider Cluster | $26.15 $17.90 | ▲ +31.55% | ▲ +29.57% | $15.20 (+41.87%) |
Aug 14, 2026 6w ago | 144 | $26.15 $18.52 | ▼ −29.18% | ▼ −27.65% | $15.20 (−41.87%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▲ +27.94% | ▲ +25.95% | $15.20 (+40.86%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▼ −27.94% | ▼ −25.95% | $15.20 (−40.86%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▼ −27.94% | ▼ −25.95% | $15.20 (−40.86%) |
Jul 29, 2026 9w ago | Press Release | $25.73 $26.09 | ▲ +1.40% | ▼ −2.57% | $15.20 (−40.92%) |
Jul 22, 2026 10w ago | Press Release | $23.21 $26.78 | ▼ −15.38% | ▼ −12.48% | $15.20 (+34.51%) |
Jul 20, 2026 10w ago | 8-K | $23.45 $26.15 | ▲ +11.51% | ▲ +7.39% | $15.20 (−35.18%) |
Jun 30, 2026 13w ago | Insider Cluster | $21.79 $25.10 | ▲ +15.19% | ▲ +17.38% | $15.20 (−30.24%) |
Jun 29, 2026 13w ago | 144 | $22.21 $25.63 | ▼ −15.40% | ▼ −16.43% | $15.20 (+31.56%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access